Vyfhuis, Melissa A L <br/><br/>
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.  [electronic resource] 

 -  Advances in radiation oncology   
 - 259-269 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2452-1094 
<br/><br/><label>Standard No.: </label>10.1016/j.adro.2017.07.009  doi